Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
NCT06565416 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225
Last updated 2025-11-12
Summary
The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.
Conditions
- Opioid Use Disorder
- Opioid Misuse
- Chronic Pain
Interventions
- BEHAVIORAL
-
Implementation Strategies
Culturally centering screening and brief intervention for chronic pain and opioid misuse/opioid use disorder among American Indian/Alaska Native clients
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of New Mexico
lead OTHER
Principal Investigators
-
Matthew R Pearson, PhD · University of New Mexico
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2026-07-31
- Completion
- 2028-07-31
Countries
- United States
Study Locations
More Related Trials
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Symptom-inhibited Fentanyl Induction
NCT05905367 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
NCT03337009 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Trial of Directly Observed and Long-term Varenicline
NCT03365362 ·Status: COMPLETED ·Phase: PHASE4
-
Guiding Aging Long-Term Opioid Therapy Users Into Safer Use Patterns
NCT05808127 ·Status: COMPLETED ·Phase: NA
-
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
NCT01046539 ·Status: COMPLETED ·Phase: PHASE1
-
Electronic Intervention to Chronic Opioid Therapy
NCT04198961 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing
NCT05307458 ·Status: UNKNOWN
-
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
NCT05706311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
NCT03936985 ·Status: COMPLETED
-
Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
NCT04939623 ·Status: RECRUITING ·Phase: PHASE2
-
Optimizing Outcomes Using Suboxone for Opiate Dependence
NCT00591617 ·Status: COMPLETED ·Phase: NA
-
Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction
NCT01562353 ·Status: UNKNOWN
-
Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication.
NCT01770314 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Trial of Opioid Taper Support
NCT01883882 ·Status: COMPLETED ·Phase: NA
-
Improving Insomnia in Patients With Opioid Use Disorder
NCT05588726 ·Status: WITHDRAWN ·Phase: NA
-
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 ·Status: COMPLETED
-
Negating Opioid and Pain Actively Through Intervention
NCT03306147 ·Status: COMPLETED ·Phase: NA
-
Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment
NCT06367387 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD
NCT04316559 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
NCT00000327 ·Status: WITHDRAWN ·Phase: PHASE2
-
PRimary Care Opioid Use Disorders Treatment (PROUD) Trial
NCT03407638 ·Status: COMPLETED ·Phase: NA
-
Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder
NCT02502175 ·Status: COMPLETED ·Phase: PHASE3
-
Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
NCT00630201 ·Status: COMPLETED ·Phase: PHASE3
-
Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
NCT00007527 ·Status: COMPLETED ·Phase: PHASE4